Segments
CARDIOLOGY
Branch of medicine that deals with the function and diseases of the heart
Cardiology
Early detection of myocardial infarction
Anyone can have a heart attack. If the blood flow in the heart is disturbed (ischemia), usually caused by a clot in a vessel, the oxygen supply to the heart is disturbed and the affected heart muscle cells begin to die after a short time. This leads to what is known as an acute myocardial infarction (AMI), or heart attack. In this situation every second counts, but the classic biomarker can only be a beginning
Recognize necrosis - which is actually too late.
New opportunities
Early diagnosis using the Diacordon line of products can speed up the decision on the right treatment. Irreversible damage to heart muscle cells and unnecessarily complex treatments (catheterization) can be reduced or avoided in certain cases.
77.000.000
HEART ATTACK PATIENTS
RISK FACTORS:
HIGH BLOOD PRESSUREUNHEALTHY LIFESTYLE
OVERWEIGHT (INCREASED 27%)
GENETIC CONDITIONS
DIAGENICS has patented antibodies to this enzyme and has already developed a new product line for the early diagnosis of chest pain patients for the detection of heart attacks: DIACORDON®. Current and future studies will also expand our knowledge in the field of heart attack diagnosis and the success of the course of treatment (monitoring).
Cardiology
Our Products
DIACORDON® POCT
DIAGENICS Group SE
DIACORDON® ELISA
DIAGENICS Group SE
DIACORDON® READER
DIAGENICS Group SE